Abstract-Reperfusion of globally ischemic rat hearts causes the generation of inositol (1, 4, 5) trisphosphate [Ins(1, 4, 5)P 3 ] and the initiation of arrhythmias. These responses are mediated by ␣ 1 -adrenergic receptors (ARs), but the subtype of receptor involved has not been identified. Under normoxic conditions, hearts from transgenic animals expressing constitutively active ␣ 1B -ARs in heart (␣ 1B -constitutively active mutant [CAM]) showed higher [ 3 H] inositol phosphate responses to norepinephrine (2.3-fold) than hearts from nontransgenic animals (␣ 1B -WT) (1.6-fold). ␣ 1B -WT hearts responded to 2 minutes of reperfusion after 20 minutes of global ischemia by generation of Ins(1,4,5)P 3 (5301Ϯ1310 to 11 413Ϯ1597 CPM/g tissue; meanϮSEM; nϭ6; PϽ0.01 in [
S
ympathetic control of cardiac function involves most importantly ␤-ARs that mediate their effects primarily by activation of adenylyl cyclase and consequent stimulation of the protein kinase A cascade. The heart also contains ␣ 1 -ARs that do not play a major functional role under normal physiological conditions but increase in relative importance under pathological conditions, including ischemia and postischemic reperfusion, 1 as well as some forms of heart failure.
2,3 ␣ 1 -Receptors have been implicated in the genesis of arrhythmias under these pathological conditions. 2, 4 ␣ 1 -Receptors activate the phosphatidylinositol (PtdIns)-specific phospholipase C with the generation of inositol phosphates (InsPs) and sn-1,2-diacylglycerol. Unlike most other cell types, however, large increases in inositol (1, 4, 5) trisphosphate [Ins(1,4,5)P 3 ] are not observed when intact heart tissue is stimulated with ␣ 1 -adrenergic agonists. 5 The heart contains a relatively low concentration of Ins(1,4,5)P 3 receptors, 6, 7 and these do not appear to be localized primarily on Ca 2ϩ stores. Responses to Ins(1,4,5)P 3 are slow and weak, 8 and the Ca 2ϩ so generated does not contribute to calciuminduced calcium release. 9 Thus Ins(1,4,5)P 3 is unlikely to be important in regulating beat-to-beat changes in Ca 2ϩ under physiological conditions.
In contrast to findings under physiological conditions, reperfusion after global ischemia causes a rapid, transient generation of Ins(1,4,5)P 3 . 10 This response is dependent on norepinephrine, either exogenously added or released from sympathetic nerves, and is mediated via ␣ 1 -ARs. More importantly, generation of Ins(1,4,5)P 3 was shown to be necessary for the initiation of reperfusion arrhythmias under these conditions. 11, 12 Inhibition of the ␣ 1 -receptor-mediated Ins(1,4,5)P 3 response thus provides a suitable target for the development of antiarrhythmic agents.
Heart contains both ␣ 1A -and ␣ 1B -ARs expressed at the protein level. In rat, Ϸ80% of the expressed receptor proteins are of the ␣ 1B -subtype, whereas in human tissue, the receptors are mostly ␣ 1A -subtype. ␣ 1D -Receptors do not appear to be expressed in heart at the protein level. [13] [14] [15] [16] Both the ␣ 1A -and ␣ 1B -receptor classes can generate InsPs in isolated cell systems. 17 In intact rat and rabbit heart, under normoxic conditions, InsP generation appears to be mediated primarily by ␣ 1B -receptors, 18 but the contribution from the ␣ 1A -subtype increases with cardiomyocyte isolation and culture. 15, 19 Furthermore, ␣ 1A -receptor activity has been associated with pathological changes leading to hypertrophy in isolated cells and in hearts in vivo. 19, 20 The current studies were undertaken to investigate the subtype of ␣ 1 -receptor involved in mediating inositol phosphate responses in heart under conditions of postischemic reperfusion. Studies were performed using transgenic mice with cardiac targeted expression of constitutively active ␣ 1B -ARs. These mutant receptors have high activity in the absence of agonist and, in addition, show increased agonist affinity and increased maximal activation by added agonist. 21 It was reasoned that if the reperfusion response is mediated via ␣ 1B -ARs, then a heightened activity would be expected in ␣ 1B -constitutively active mutant (CAM) hearts. Thus these experiments investigated the activity of the constitutively active ␣ 1B -ARs under normoxic conditions and under conditions of postischemic reperfusion.
Materials and Methods

Animals
Parent ␣ 1B -CAM mice were generated at the Howard Hughes Medical Institute, Duke University. The mutant receptor is expressed under an ␣-myosin heavy chain promoter, as described previously. 22 Female mice derived from F 1 crosses made from SJL and C57 strains were used to breed with heterozygotic male ␣ 1B -CAM (transgenic/ positive) mice. Animals were screened for the transgene using Southern blot hybridization of DNA extracted from tail biopsies. Approximately 50% of the offspring were ␣ 1B -CAM. Negative (␣ 1B -WT) littermates were used as controls. Both male and female mice were used in equal numbers, ranging in age from 12 to 30 weeks. No differences in responses were observed between male and female animals. Where indicated, mice were treated with reserpine (3 mg/kg IP) 24 hours before experimentation to deplete endogenous catecholamines. The procedure resulted in a reduction of cardiac norepinephrine, measured as described previously, 23 from 559Ϯ52 to 9.5Ϯ4.7 ng/g wet weight (meanϮSEM; nϭ4; PϽ0.01).
[ 3 H]InsPs in Isolated Perfused Mouse Hearts
Adult mice were injected with heparin (5 IU/g) for 30 minutes before killing by cervical dislocation. Hearts were removed and chilled immediately in ice-cold saline. For experiments under normoxic conditions, hearts were perfused with norepinephrine (100 mol/L) for 20 minutes and then were frozen in liquid N 2 and subsequently weighed, and InsPs were extracted.
For experiments investigating ischemia and reperfusion, hearts were subjected to global ischemia by turning off the perfusion pump and the oxygen flow. Reperfusion was achieved by restarting flow of medium and oxygen. After 2 minutes of reperfusion, hearts were frozen in liquid N 2 and weighed subsequently and InsPs extracted.
Extraction and Quantitation of [ 3 H]InsPs
InsPs were extracted from frozen ventricles in 2 mL of 5% trichloroacetic acid (TCA) containing 2.5 mmol/L EDTA and 5 mmol/L phytic acid using a "Polytron" homogenizer followed by sonication as described previously. 10 After centrifugation at 5000g for 10 minutes (4°C) , supernatants were removed, and TCA pellets were re-extracted with 1 mL TCA. The combined aqueous phases were pooled and extracted with a 1:1 mixture of freon and tri-Noctamylamine (0.75 mL/mL of supernatant). The final aqueous phase was collected and treated with proteinase K (50 g/mL; 2 hours; 50°C), and the samples then were passed through a 1-mL Dowex-50 column (4% cross-linked 4-400 mesh size) and eluted with 1 mL of water. Urea (0.05 mol/L final) was added and samples lyophilized before high-performance liquid chromatography (HPLC) analysis. 24 [
3 H]-Labeled InsPs were separated using anion-exchange HPLC and quantitated using an on-line ␤-counter (Radiomatic Instruments Model CR) as described previously. was eluted with 7 mL of 1 mol/L ammonium formate and 0.1 mol/L formic acid. Samples were counted using a ␤-counter. The [ 3 H]-labeled lipids were identified as PtdIns, PtdIns(4)P, and PtdIns(4,5)P 2 by removing the mobile phase with repeated lyophilization and then performing anion-exchange HPLC as described above.
Measurement of Ins(1,4,5)P 3 and PtdIns(4,5)P 2 Mass
For measurement of Ins(1,4,5)P 3 mass, unlabeled tissue was extracted in 2 mL of 5% TCA, 2.5 mmol/L EDTA, and 5 mol/L ATP as described above. The procedure was similar to that described for [ 3 H]InsPs, except that the proteinase K step was omitted and urea was not added before lyophilization. 24 Lyophilized samples were dissolved in water and neutralized with NaHCO 3 plus NaOH, as required. Ins(1,4,5)P 3 content of the neutralized samples was quan-titated by using a commercial competitive binding assay involving an Ins(1,4,5)P 3 receptor preparation and [
3 H]Ins (1,4,5) P 3 , according to the manufacturer's instructions (Amersham).
For measurement of PtdIns(4,5)P 2 mass, lipids were extracted from the TCA pellets remaining after Ins(1,4,5)P 3 extraction from unlabeled tissue and deacylated after the method described above. The deacylated lipids were deglycerated by adding sodium periodate (10 mmol/L) for 30 minutes, followed by 15 minutes of incubation with ethylene glycol (10% vol/vol). The reaction was completed using dimethylhydrazine (0.4%) treatment for 3 hours. Samples were neutralized and lyophilized. 25 Mass assay of the Ins(1,4,5)P 3 resulting from deacylation and deglyceration of PtdIns(4,5)P 2 was carried out as above.
The identity of the compound measured in the assay as Ins(1,4,5)P 3 [and thus the progenitor lipid as PtdIns(4,5)P 2 ] was validated by treating aliquots of representative samples with pure Ins(1,4,5)P 3 5Ј-phosphatase (10 ng) for 30 minutes at 37°C followed by boiling to inactivate the enzyme. This treatment removed material that displaced [ 
Measurement of mRNA
Total RNA was prepared using the acid guanidinium thiocyanate procedure. 26 RNA concentration was determined by absorbance at 260 nm. Levels of ␣ 1A -and ␣ 1B -mRNA transcripts were measured by RNase protection analysis. A 746-nucleotide fragment of the rat ␣ 1A -receptor cDNA corresponding to nucleotides 1 to 746 of the published sequence, 27 and a 471-nucleotide fragment of the hamster ␣ 1B -cDNA corresponding to nucleotides 1 to 471 28 were subcloned into pGEM-4Z vectors for generation of cRNA probes as previously described. 29 Sense RNA was synthesized in vitro from each template and served to generate a standard curve for each RNA species so that the absolute level of these RNA transcripts could be determined in heart RNA extracts. RNA standards and samples (5 L), 20 L of hybridization buffer (80% formamide; 40 mmol/L PIPES, pH 6.7; 0.4 mol/L NaCl; 1 mmol/L EDTA) and 5 L of antisense probe (reconstituted in hybridization buffer) were hybridized overnight at 45°C. After hybridization, samples were digested at 37°C for 60 minutes by addition of 300 L of RNase buffer (300 mmol/L NaCl; 10 mmol/L Tris, pH 7.5; 5 mmol/L EDTA with 400 U RNase T1) and the protected hybrids purified by incubation with 5 L proteinase K (10 mg/mL) and 20 L sodium dodecyl sulfate (10%) for 15 minutes at 37°C, followed by isopropanol precipitation. RNA hybrids were then resolved on nondenaturing 4% acrylamide gels. Absolute quantitation of unknown ␣ 1A -and ␣ 1B -mRNA transcripts in molar terms was achieved by comparison with a standard curve after analysis on a Fuji BAS-1000 phosphorimaging system. Atrial natriuretic peptide (ANP) mRNA was measured by RNase protection exactly as described previously.
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Arrhythmogenic Responses
Mice were anesthetized with pentobarbital (60 mg/kg IP) and given heparin (20 IU IV). Hearts were cannulated in situ via the ascending aorta, using a dissecting microscope and perfused at 2 mL/min with Krebs-Henseleit medium constantly gassed with 5% CO 2 /95% O 2 (pH 7.4) at 37°C. 31 The perfusate included propranolol (1 mol/L) to block ␤-ARs and LiCl (10 mmol/L) to replicate the conditions used in studies of inositol phosphate generation. This preparation is essentially similar to a standard Langendorff preparation except that the heart remains attached to the open chest of the animal and the perfusion flow rate is controlled by a peristaltic pump. 31 The signal electrode was superficially connected to the left ventricular wall and the reference electrode to the aorta. ECG was recorded throughout the experiment. A 10-minute period was allowed to stabilize the preparation before the experiment, and then the left main coronary artery was ligated to produce regional ischemia. Reperfusion was achieved by removing the ligature. The effectiveness of the ligation was assessed by 2 methods. First, a rise in perfusion pressure (30% to 50%) was observed. The perfusion flow rate was adjusted coincidentally with coronary occlusion and reperfusion to maintain a constant coronary perfusion pressure throughout the experiment.
Second, at the end of the experiment, the coronary artery was reoccluded, and the hearts were perfused with Evans Blue (10% 0.05 mL). A nonstained area of left ventricle (LV), indicative of lack of perfusion, was visualized. The incidence of reperfusion arrhythmias was not altered by propranolol or LiCl, alone, or in combination. During the 20 minutes of ischemia and 5 minutes of reperfusion, the epicardial ECG and the coronary perfusion pressure were monitored. Unlike our previous findings in rat heart, 11 and in agreement with the work of other laboratories, 32 ventricular fibrillation was not observed in the mouse hearts either during the ischemic or reperfusion periods. Ventricular arrhythmias expressed as ventricular premature beats (VPB) and ventricular tachycardia ([VT] defined as at least 5 consecutive ectopic beats) were quantified according to the Lambeth Convention guidelines and as depicted in Figure 1 .
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Coronary Artery Occlusion and Reperfusion In Vivo
Mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (20 mg/kg IP). After tracheal intubation, artificial ventilation with a Harvard ventilator was started (0.5 mL tide volume; 80 strokes/min). A left thoractomy was performed to expose the heart, and after 10 minutes of stabilization, the left coronary artery was ligated using 7-0 silk suture enclosing 2 releasing rings. The chest was then closed, leaving the suture and the releasing rings accessible from outside the chest. After 40 minutes of occlusion, the ligature was released from outside the chest to allow 60 minutes of reperfusion.
Measurement of Area at Risk and Infarct Zone
The zone at risk (RZ) and the infarcted zone (IZ) were determined as described elsewhere. 34 In brief, at the end of the reperfusion period, the ascending aorta was cannulated and the heart isolated. After washing the coronary vasculature with cold saline, the coronary artery was reoccluded, followed by infusion of 0.1 mL 10% Evans Blue to stain the nonischemic area. The excess dye was washed away, and large vessels, atria, and the right ventricle were removed. The LV was then frozen, cut transversely into Ϸ1-mm thick slices (6 to 7 slices per heart), and incubated with 1.5% triphenyltetrazolium in 100 mmol/L PBS (pH 7.4) for 15 minutes at 37°C. The viable myocardium were stained brick red, and the infarcted myocardium became pale white. The stained slices were mounted on a glass plate, photographed, and enlarged. The 3 areas, nonischemic area, RZ, and IZ, were outlined and quantified using a software program (BioScan Optimas).
Statistics
Values presented are meanϮSEM. Statistical analysis of inositol phosphate data involved the use of 1-way ANOVA followed by Student unpaired t test. Significance was determined at PϽ0.05. Chi-square or Fisher exact test was used for percentages of VPB and Hearts were subjected to 20 minutes of regional ischemia followed by 5 minutes of reperfusion, as described in Materials and Methods. Typical ECG recordings are shown.
VT. The Mann-Whitney rank sum test was used for VPB number and VT duration. 
Materials
Results
Effects of the ␣ 1B -CAM Receptors on Heart Weight and ANP Gene Transcription
Hearts from the ␣ 1B -CAM animals bred in our animal facility did not show signs of hypertrophy in terms of tissue weight (Table 1) , even though a mild 10% to 20% increase in heart weight has been reported previously in this strain. 22 Increased ANP gene transcription was observed, as reported previously, suggesting a sensitivity to the development of hypertrophy. Differences in diet or housing conditions most likely explain these differences.
InsP Responses in ␣ 1B -WT and ␣ 1B -CAM Hearts Under Physiological Conditions
The effect of the CAM ␣ 1B receptors on the contents of InsPs and inositol phospholipids was investigated in perfused mouse hearts under normoxic conditions. Isolated mouse hearts were labeled with [ 3 H]inositol, pretreated with propranolol and LiCl, and then perfused with norepinephrine (100 mol/L) or vehicle for 20 minutes in the continued presence of propranolol and LiCl. [ 3 H]InsPs and inositol phospholipids were extracted and quantitated. In the absence of added norepinephrine, hearts from ␣ 1B -CAM animals contained higher levels of [ 3 H]inositol-labeled InsPs and phospholipids than ␣ 1B -WT ventricles (Table 2; Figure 2 ). In parallel experiments, mass contents of PtdIns(4,5)P 2 and Ins(1,4,5)P 3 were measured in unlabeled hearts from each group of animals. The mass contents of PtdIns(4,5)P 2 and Ins(1,4,5)P 3 were not different between the 2 groups (Table 2; Figure 2 ). Hearts from ␣ 1B -CAM mice also showed higher total [ 3 H]InsP responses to norepinephrine than ␣ 1B -WT hearts. Thus the ␣ 1B -CAM receptor expressed in intact heart shows constitutive activity and an enhanced response to norepinephrine as described previously for this mutant expressed in COS cells. 21 Although both ␣ 1B -WT and ␣ 1B -CAM hearts responded to norepinephrine with an increase in [ Figures  3 and 4) . As described previously in rat heart, 10 increases in [
InsP Responses During Early Reperfusion in ␣ 1B -WT and ␣ 1B -CAM
3 H]Ins(1,4,5)P 3 were observed, and in parallel studies, an increase in Ins(1,4,5)P 3 mass was demonstrated (Figure 4 ). This shows that the changes observed in the labeling studies reflected mass changes rather than solely an increase in specific activity. As described previously for rat hearts, 12 3 CPM/g tissue; meanϮSEM; nϭ4; PϾ0.05 in both cases) was detected when hearts were reperfused in the presence of added excess norepinephrine (100 mol/L). This eliminates the possibility of differences related to norepinephrine availability.
Reperfusion Arrhythmias in ␣ 1B -WT and ␣ 1B -CAM Hearts
Reperfusion arrhythmias were measured over a 5-minute period after 20 minutes of regional ischemia in perfused mouse hearts, as described in Materials and Methods. Ventricular fibrillation was not detected in the mouse hearts under these conditions, 32 but VPB and VT were observed in ␣ 1B -WT hearts. The incidence of reperfusion-induced VPB and VT were significantly lower in the ␣ 1B -CAM hearts, in agreement with the finding of lower generation of Ins(1,4,5)P 3 ( Figure 1 ; Table 3 ).
Effect of Thrombin Receptor Activation During Reperfusion
Failure to detect a reperfusion response in ␣ 1B -CAM hearts could mean either that ␣ 1B -receptors are not involved in mediating the InsP response to norepinephrine under reperfusion conditions or that the presence of the active ␣ 1B -receptors has had a preconditioning effect. 36 In previous studies, we have shown that under reperfusion conditions, thrombin receptor activation causes similar Ins(1,4,5)P 3 and arrhythmogenic responses. 12 Any preconditioning effect of ␣ 1B -CAM receptors would be expected to affect responses to ␣ 1 -receptor or thrombin receptor activation. Thus responses to thrombin receptor stimulation were investigated in ␣ 1B -WT and ␣ 1B -CAM hearts. Catecholamine-depleted hearts from ␣ 1B -WT or ␣ 1B -CAM mice were subjected to 20 minutes of ischemia followed by reperfusion in the presence of thrombin receptor activating peptide (TRAP, SFLLRN; 50 mol/L). Ins(1,4,5)P 3 content was measured after 2 minutes. As shown in Figure 5 , addition of TRAP to catecholamine-depleted ␣ 1B -WT hearts caused generation of Ins(1,4,5)P 3 . The TRAP response was quantitatively similar to the response to norepinephrine. Similar experiments were performed using ␣ 1B -CAM hearts. Addition of TRAP (50 mol/L) to ␣ 1B -CAM hearts for the 2-minute reperfusion period caused an increase in Ins(1,4,5)P 3 similar to that observed in ␣ 1B -WT hearts. Thus the ␣ 1B -CAM receptor reduces the reperfusion-induced Ins(1,4,5)P 3 response only when this is activated by ␣ 1 -adrenergic agonists. This argues against preconditioning as an explanation.
Infarct Size Measurements in ␣ 1B -WT and ␣ 1B -CAM Hearts
Preconditioning would be expected to reduce infarct size after coronary artery ligation as well as reducing arrhythmias. 36 Experiments were performed to measure infarct size in hearts from ␣ 1B -WT and ␣ 1B -CAM animals after ischemia/reperfusion in vivo. There was no difference between control and ␣ 1B -CAM groups (nϭ7 per group) in the RZ (45Ϯ4% versus 50Ϯ4% of LV; PϭNS) or IZ (32Ϯ4% versus 31Ϯ3% of LV; PϭNS). The infarct size, calculated from the ratio of IZ/RZ (%) was also similar between the 2 groups (67Ϯ4% versus 62Ϯ6%; PϭNS).
Expression of ␣ 1A -Receptors in ␣ 1B -CAM Hearts
␣ 1B -CAM hearts did not generate Ins(1,4,5)P 3 in early reperfusion, providing evidence that the response is not ␣ 1B -receptormediated. As hearts express only ␣ 1B -and ␣ 1A -receptors with minimal expression of ␣ 1D -receptors at the protein level, 15 this implicates ␣ 1A -receptor involvement in mediating the reperfusion response and implies that ␣ 1A -receptor activity is depressed in ␣ 1B -CAM hearts. Thus the effect of the ␣ 1B -CAM receptors on the expression of ␣ 1A -receptors was investigated. RNA was extracted from ␣ 1B -CAM and ␣ 1B -WT hearts, and the content of mRNA for ␣ 1A -and ␣ 1B -receptors was quantitated by RNase protection. The content of ␣ 1B -receptor mRNA in the ␣ 1B -CAM hearts, expressed under the myosin heavy chain promoter, was markedly increased (26-fold) relative to ␣ 1B -WT hearts. The level of expression of ␣ 1B -receptor mRNA under the ␣-MHC promoter in the ␣ 1B -CAM hearts was very constant between animals, but there was greater variation between animals in expressions of ␣ 1A -and ␣ 1B -receptor mRNAs expressed under their own promoters. Hearts from ␣ 1B -WT animals contained mRNA for both receptor classes, but the ␣ 1B -receptors were expressed more strongly, accounting for 5 times more mRNA than the ␣ 1A -receptors. More importantly, although there was considerable variation between animals, the expression of the mRNA for ␣ 1A -receptors on average was depressed in the ␣ 1B -CAM hearts (Figure 6 ), raising the possibility of lower levels of expression of ␣ 1A -receptors in the ␣ 1B -CAM hearts. The expression of mRNA for GAPDH was similar in ␣ 1B -WT and ␣ 1B -CAM hearts ( Figure 6 ).
Discussion
Reperfusion of rat hearts after global ischemia causes release of norepinephrine from the sympathetic nerves, the transient generation of Ins(1,4,5)P 3 within the myocardium, and the initiation of arrhythmias. 10, 11, 37 As increases in Ins(1,4,5)P 3 are not detectable in intact heart under physiological conditions in response to norepinephrine, this marks a major change in the operation of the inositol phosphate pathway. Delineating the relative roles of the ␣ 1 -receptor subtypes in mediating InsP responses under normoxic and reperfusion is thus of central importance.
Under normoxic conditions, the constitutively active ␣ 1B -receptors conferred on the expressing hearts a heightened InsP response in the presence or absence of norepinephrine ( Figure 2 ). If ␣ 1B -receptors mediated the norepinephrine response during reperfusion, then generation of very large amounts of Ins(1,4,5)P 3 would be expected in ␣ 1B -CAM hearts. However, this was not found to be the case. Hearts from ␣ 1B -WT animals responded to reperfusion by generation of Ins(1,4,5)P 3 as demonstrated previously in rat hearts but, in marked contrast to findings under normoxic conditions, the ␣ 1B -CAM hearts showed no detectable Ins(1,4,5)P 3 response during early reperfusion. Together with the reduced Ins(1,4,5)P 3 response, the ␣ 1B -CAM hearts had a reduced incidence of reperfusion arrhythmias. This agrees with previous findings from our laboratory of a relationship between Ins(1,4,5)P 3 generation and arrhythmias in rat heart. Rat hearts develop more substantial arrhythmias under these conditions of early reperfusion than mouse hearts, with ventricular fibrillation being observed in addition to VPB and VT. 11, 12 Ischemia has been shown to cause the translocation and activation of PKC, 38 and this together with any sn-1,2-diacylglycerol generated along with Ins(1,4,5)P 3 might be important in arrhythmogenesis. 39 However, our studies in rat hearts showed no antiarrhythmic action of inhibitors of protein kinase C during reperfusion. 11 More importantly, recent studies from other laboratories have demonstrated a direct proarrhythmic action of Ins(1,4,5)P 3 when applied intracellularly. 40 Thus it seems most likely that Ins(1,4,5)P 3 itself, presumably via perturbations in cytosolic Ca 2ϩ , initiates electrophysiological changes that culminate in the development of arrhythmias.
The reduced Ins(1,4,5)P 3 response during reperfusion of ␣ 1B -CAM hearts suggests that the norepinephrine response is not mediated by ␣ 1B -receptors under these conditions. However, it is also possible that the ␣ 1B -CAM receptors have caused a preconditioning effect. We have shown previously that preconditioning can reduce the reperfusion Ins(1,4,5)P 3 response, 41 and others have demonstrated a preconditioning effect of ␣ 1B -receptor activation under some conditions. 36, 42 However, 2 different experiments Figure 6 . Expression of ␣ 1A -and ␣ 1B -AR mRNA in whole mouse heart. Left, Solution hybridization/RNase protection of (A) in vitro synthesized sense RNA standards, (B) ␣ 1A -AR mRNA, (C) ␣ 1B -AR mRNA, and (D) GAPDH mRNA after polyacrylamide gel electrophoresis and phosphorimaging analysis. Total RNA (20 g) derived from either ␣ 1B -WT or ␣ 1B -CAM mouse heart was used for analysis of ␣ 1 -AR mRNA, whereas 4 g RNA was hybridized to the GAPDH probe. Exposure times were 4 h for GAPDH and ␣ 1B -AR and 24 h for ␣ 1A -AR mRNA. Right, Quantitation of ␣ 1A -and ␣ 1B -AR mRNA expressed as amol-specific mRNA transcript per microgram total RNA and GAPDH mRNA expressed as percentage of control. Data represent meanϮSEM, nϭ6. *PϽ0.05 compared with respective control. Regression analyses of sense RNA standards showing linear standard curves used for the quantitation of ␣ 1A -AR mRNA are shown in the top right panel.
argue against preconditioning as an explanation of the reduced reperfusion response in the ␣ 1B -CAM hearts. First, ␣ 1B -CAM hearts responded to thrombin receptor activation under reperfusion conditions in a similar manner to ␣ 1B -WT hearts. Preconditioning would be expected to reduce responses to all effectors similarly. Second, preconditioning would also be expected to reduce infarct size after coronary artery ligation, 36 but infarct sizes were found to be similar in the 2 groups. Thus no evidence was found for a preconditioning effect of the ␣ 1B -CAM receptors under the conditions of our experiments.
The data presented indicate the involvement of ␣ 1 -receptors other than ␣ 1B -subtype as mediators of the reperfusion-induced Ins(1,4,5)P 3 response to norepinephrine. Hearts, at least human and rat, express only the ␣ 1A -and ␣ 1B -subtypes of ␣ 1 -receptors at the protein level. 15 If also true of mouse heart, this implies an involvement of ␣ 1A -receptors. Such an interpretation however, suggests a reduction in ␣ 1A -receptor activity in the ␣ 1B -CAM hearts. Some evidence for this was supplied by the experiments showing reduced ␣ 1A -receptor mRNA expression in the ␣ 1B -CAM hearts (Figure 1) . However, it must be stressed that an involvement of ␣ 1D -receptors cannot be discounted at this stage. We have reported previously that stimulation of ␣ 1A -receptors causes a reduction in ␣ 1B -receptor mRNA. 43 Together with data reported here, this points to a reciprocal relationship between these 2 receptor subclasses, at least in the myocardium.
An involvement of receptors with ␣ 1A -specificity in the generation of arrhythmias under ischemic/reperfusion conditions has been suggested previously on the basis of effects of selective antagonists. [44] [45] [46] [47] In addition, increased activity of ␣ 1A -receptors has been shown to be associated with the development of other pathological conditions such as hypertrophy and failure, with hypertrophic agents causing an increase in expression of ␣ 1A -receptor mRNA together with a decrease in ␣ 1B -receptor expression. 20 ␣ 1A -ARs in heart thus appear to be involved in several different pathologies, and subtype-selective antagonists might prove useful in protecting the heart under several different pathological conditions.
